Industry NewsDual-Targeted CAR T-cell Line Shows Promising Results in Preclinical Cancer Immunotherapy Study
Industry NewsSelective Inhibitor BLU-667 Demonstrates Early Promise in Patients With RET-Altered Cancers
Editorial ArticleFrom Contender to Unanimous Choice – When a Demo Instrument Makes a Lasting Impression
Editorial ArticleSelectScience to Provide Exclusive AACR 2018 Show Coverage and Reveal Winners of the Life Sciences Scientists’ Choice Awards
Product NewsNew Distributor to Increase Availability of Livecyte Platform Throughout the USA and Canada
